 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1924 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed IF you are interested in this trial, contact them as soon as possible, as there is a strict window of opportunity to join. Some of our members missed by a few days. |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
04/29/2012 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
See Novocure for more information on this device! |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
Santosh Kesari MD, Phd Director, Neuro-Oncology UCSD Moores Cancer Center 3855 Health Sciences Drive, MC0819 La Jolla, CA 92093 USA Phone: (858) 822-7524 Fax: (858) 822-6287 E-mail: skesari@ucsd.edu Website: cancer.ucsd.edu/summaries/skesari.asp |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|